|
| |
Carcinoma Intraductal NoninfiltratingDownload PDF containing detailed information.
Recent Publications on Carcinoma Intraductal Noninfiltrating: |  |
Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.
Low-grade precursor lesions, such flat epithelial atypia (FEA), low-grade... | 13th November, 2009
| Institute of Pathology, Heidelberg University, Heidelberg, Germany.
| Am J Surg Pathol. 2009 Nov;33(11):1646-53.
DOI Direct Link |
Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
The presence of atypical or usual epithelial proliferations within... | 13th November, 2009
| Department of Laboratory Medicine and Pathobiology, University of Toronto,
| Am J Surg Pathol. 2009 Nov;33(11):1615-23.
DOI Direct Link |
Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?
BACKGROUND: The purpose of this survey was to ascertain the most common... | 11th November, 2009
| University of California San Diego, Moores Cancer Center, 3855 Health
| J Am Coll Surg. 2009 Nov;209(5):608-13. Epub 2009 Sep 11.
DOI Direct Link |
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
The protein 14-3-3sigma is involved in the regulation of cellular... | 10th November, 2009
| Department of Pathology and Laboratory Medicine, David Geffen School of
| Cancer Biomark. 2009;5(4):215-24.
DOI Direct Link |
American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions.
BACKGROUND: A subset analysis of the American Society of Breast Surgeons... | 20th October, 2009
| Aventura Comprehensive Cancer Center, Aventura, FL, USA.
| Am J Surg. 2009 Oct;198(4):505-7.
DOI Direct Link |
→View more research publications. |
Press Releases About Carcinoma Intraductal Noninfiltrating:
|
 |
| Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting |
17th November, 2009 |
Oncolytics Biotech Inc. |
CALGARY, Nov. 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K.
|
| Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting |
16th November, 2009 |
Oncolytics Biotech Inc. |
CALGARY, Nov. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced that a poster presentation covering updated
|
| Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting |
29th October, 2009 |
Onyx Pharmaceuticals, Inc. |
-- Late Breaker #9
First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial)
-- Dr. Andreas Erhardt, Klinik fur
|
| Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma |
19th October, 2009 |
Jennerex, Inc. |
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
|
| AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago |
29th September, 2009 |
AETERNA ZENTARIS INC. |
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and
Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed
after Failing Treatment with both a VEGF
|
BioPortfolio Ltd. offers e-mail and postal lists for Carcinoma Intraductal Noninfiltrating scientists - we have details of around 588 individuals working on Carcinoma Intraductal Noninfiltrating .
This page has been viewed 376 times
Recent Search Terms used to find this page: stage 2 noninfiltrating ductal carcinoma | intraductal papillary carcinoma infiltrat mammae | carcinoma intraductal non-infiltrating breast | intraductalt carcinom | carcinoma intraductale | carcinoma intraductale | breast carcinoma intraductal | carcinoma intraductale | carcinoma intraductale | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Carcinoma Intraductal Noninfiltrating across BioPortfolio, or for Carcinoma Intraductal Noninfiltrating Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
